LCM
EPZM

Landscape Capital Management’s Epizyme, Inc EPZM Stock Holding History

Landscape Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,100
Closed -$40K – 1041
2021
Q4 		$40K Buy
+16,100
New +$63.3K 0.01% 812
2018
Q1 		– Sell
-51,077
Closed -$641K – 732
2017
Q4 		$641K Buy
+51,077
New +$742K 0.06% 331

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Landscape Capital Management's EPZM Position: Q1 2022 in Review

Landscape Capital Management sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 16,100 shares — an estimated $40K sold.

Landscape Capital Management first reported a position in EPZM in Q4 2017 and held it in 2 quarters. The position peaked at $641K in Q4 2017. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Landscape Capital Management reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Landscape Capital Management sold 16,100 Epizyme, Inc shares in Q1 2022, an estimated $40K.
  • Landscape Capital Management first reported a position in Epizyme, Inc in Q4 2017 and held it in 2 quarters.
  • Landscape Capital Management's Epizyme, Inc position peaked at $641K in Q4 2017.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Landscape Capital Management's 13F filing for Q1 2022, filed 11 May 2022.